ANRO (Alto Neuroscience Inc) Rega marang bathi mangsa ngarep

Logo grafis Alto Neuroscience, Inc. (ANRO)

Attracting top neurobiologists and data scientists through stock options builds the intellectual capital of Alto Neuroscience, Inc. (ANRO). The company's current forward P/E visualizes this bet on innovation, where the value of 0.00 reflects the metric's balance. The high macro-resilience of R&D processes isolates the company from economic cycles, although significant clinical trial expenditures temporarily constrain net margins.

Kapitalisasi marang proyeksi bathi: Alto Neuroscience Inc (ANRO) kanggo 21.02.2024 - 15.11.2026

Rincian metrik lan analitis perusahaan Alto Neuroscience, Inc. (ANRO)

- rega saiki lan proyeksi nilai saham:
Kutipan saham Alto Neuro|ANRO - Konsensus nilai wajar
- indikator valuasi pasar bisnis:
Nilai pasar Alto Neuro|ANRO - Nilai Wutuh Bisnis
- data ekuitas miturut neraca:
Aset Bersih saben Siji Saham Alto Neuroscience|ANRO - Pambiji Buku Bisnis|Rasio Kapitalisasi marang Aset Bersih altoneuroscience.com|ANRO - Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Alto Neuroscience, Inc.|ANRO - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Alto Neuroscience|ANRO - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Alto Neuroscience Inc|ANRO - Utang jangka dawa|Utang jangka cendhak perusahaan Alto Neuroscience|Likuiditas cepet altoneuroscience.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ANRO - Bathi resik perusahaan|Bathi mangsa ngarep Alto Neuroscience, Inc.|ANRO - Rasio rega pasar marang bathi resik|Rega marang bathi mangsa ngarep Alto Neuroscience Inc|ANRO - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Alto Neuroscience|ANRO - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Alto Neuroscience|ANRO - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan altoneuroscience.com|ANRO - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Alto Neuroscience, Inc.
- data pendapatan lan penerimaan dodolan:
ANRO - Pendapatan lan volume dodolan|Prakiraan pendapatan perusahaan Alto Neuro|ANRO - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang prakiraan pendapatan Alto Neuroscience Inc|ANRO - Wutah pendapatan taun lumaku
Pambiji fundamental:ANRO altoneuroscience.com
Produk merek Alto Neuroscience Corp

High market expectations for Alto Neuroscience, Inc. (ANRO) often outpace actual financial achievements amid fierce competition for new treatment mechanisms for psychiatric disorders. By analyzing the dynamics of the company's forward P/E ratio, an investor assesses the current share price relative to projected net income, which helps identify the risk of business overvaluation in the event of potential drug development failures.

Pesaing Alto Neuroscience, Inc. (ANRO)

Prakiraan rega marang bathi ALKS (Alkermes Inc.)|AVDL (Avadel Corp) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep atai Life Sciences Corp ATAI|GHRS (ghres.com) - Rasio rega marang bathi sing dikarepake|MNMD - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Compass Pathways CMPS|LBRX (lbpharma.us) - Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi Bright Minds Biosciences Inc (DRUG)|VNDA (vandapharma.com) - Pangali Forward P/E|Prakiraan rega marang bathi Cybin Inc. (CYBN)|Pangali Forward P/E NRXP|CING (Cingulate Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep silopharma.com SILO|China Pharma (CPHI) - Rasio prakiraan rega marang bathi|clearmindmedicine.com - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Psyence Biomedical PBM|SPRC: Pangali Forward P/E|Rasio prakiraan rega marang bathi Seelos Therapeutics, Inc. (SEEL)|Rega marang bathi mangsa ngarep virpaxpharma.com|KRTX: Pangali mangsa ngarep rega marang bathi